VCAM1 and neoplasm: Monte Carlo simulation of radiation dose deposition showed that 212Pb-labeled anti–VCAM-1 antibodies would provide a therapeutic dose to tumor cells adjacent to blood vessels, without the need for antibodies to cross the BBB.